With 1.84 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.65 million shares. During the session, the Oil & Gas Refining & Marketing company that operates in wider Energy sector, reached to the highest price of $2.585 whereas the lowest price it dropped to was $2.51. The 52-week range on CLNE shows that it touched its highest point at $4.12 and its lowest point at $2.17 during that stretch. It currently has a 1-year price target of $7.50. Beta for the stock currently stands at 2.15.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLNE was down-trending over the past week, with a drop of -8.00%, but this was down by -6.64% over a month. Three-month performance dropped to -18.91% while six-month performance fell -5.24%. The stock lost -32.89% in the past year, while it has lost -33.94% so far this year. A look at the trailing 12-month EPS for CLNE yields -0.32 with Next year EPS estimates of -0.08. For the next quarter, that number is -0.00. This implies an EPS growth rate of 104.60% for this year and -3121.33% for next year.
Float and Shares Shorts:
At present, 223.43 million CLNE shares are outstanding with a float of 164.77 million shares on hand for trading. On 2024-11-29, short shares totaled 11.42 million, which was 511.00000000000006 higher than short shares on 1730332800. In addition to Mr. Andrew J. Littlefair as the firm’s Co-Founder, President, CEO & Director, Mr. Robert M. Vreeland CPA serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.52376 of CLNE’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, CLNE reported revenue of $104876000.0 and operating income of -$8528000.0. The EBITDA in the recently reported quarter was $1435000.0 and diluted EPS was -$0.08.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLNE since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CLNE analysts setting a high price target of 22.0 and a low target of 4.0, the average target price over the next 12 months is 7.25. Based on these targets, CLNE could surge 769.57% to reach the target high and rise by 58.1% to reach the target low. Reaching the average price target will result in a growth of 186.56% from current levels.
Analysts have provided yearly estimates in a range of $0.00986071 being high and -$0.000788857143 being low. For CLNE, this leads to a yearly average estimate of $0.002761.
